142 related articles for article (PubMed ID: 31615087)
1. Ground Calcium Carbonate as a Low Cost and Biosafety Excipient for Solubility and Dissolution Improvement of Praziquantel.
Borrego-Sánchez A; Sánchez-Espejo R; Albertini B; Passerini N; Cerezo P; Viseras C; Sainz-Díaz CI
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31615087
[TBL] [Abstract][Full Text] [Related]
2. Praziquantel-Clays as Accelerated Release Systems to Enhance the Low Solubility of the Drug.
Borrego-Sánchez A; Sánchez-Espejo R; García-Villén F; Viseras C; Sainz-Díaz CI
Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32987673
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of melt granulation and ultrasonic spray congealing as techniques to enhance the dissolution of praziquantel.
Passerini N; Albertini B; Perissutti B; Rodriguez L
Int J Pharm; 2006 Aug; 318(1-2):92-102. PubMed ID: 16697539
[TBL] [Abstract][Full Text] [Related]
4. Poly(2-Ethyl-2-Oxazoline) as an Alternative to Poly(Vinylpyrrolidone) in Solid Dispersions for Solubility and Dissolution Rate Enhancement of Drugs.
Fael H; Ràfols C; Demirel AL
J Pharm Sci; 2018 Sep; 107(9):2428-2438. PubMed ID: 29859957
[TBL] [Abstract][Full Text] [Related]
5. Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment.
Albertini B; Perissutti B; Bertoni S; Zanolla D; Franceschinis E; Voinovich D; Lombardo F; Keiser J; Passerini N
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30870971
[TBL] [Abstract][Full Text] [Related]
6. A new soluble and bioactive polymorph of praziquantel.
Zanolla D; Perissutti B; Passerini N; Chierotti MR; Hasa D; Voinovich D; Gigli L; Demitri N; Geremia S; Keiser J; Cerreia Vioglio P; Albertini B
Eur J Pharm Biopharm; 2018 Jun; 127():19-28. PubMed ID: 29409939
[TBL] [Abstract][Full Text] [Related]
7. Conformational polymorphic changes in the crystal structure of the chiral antiparasitic drug praziquantel and interactions with calcium carbonate.
Borrego-Sánchez A; Carazo E; Albertini B; Passerini N; Perissutti B; Cerezo P; Viseras C; Hernández-Laguna A; Aguzzi C; Sainz-Díaz CI
Eur J Pharm Biopharm; 2018 Nov; 132():180-191. PubMed ID: 30267834
[TBL] [Abstract][Full Text] [Related]
8. Use of calcium carbonate as an excipient for release of poorly water soluble drugs: The case of carbamazepine.
Donnadio A; Corneli C; Ricci P; Bini M; Ambrogi V
Int J Pharm; 2020 Nov; 589():119860. PubMed ID: 32911048
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.
Patel RP; Patel MM
Pharm Dev Technol; 2007; 12(1):21-33. PubMed ID: 17484141
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine.
Murali Mohan Babu GV; Prasad ChD; Ramana Murthy KV
Int J Pharm; 2002 Mar; 234(1-2):1-17. PubMed ID: 11839433
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.
Madan JR; Pawar AR; Patil RB; Awasthi R; Dua K
Polim Med; 2018; 48(1):17-24. PubMed ID: 30657654
[TBL] [Abstract][Full Text] [Related]
12. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of a new solid form of praziquantel, an essential anthelmintic drug. Praziquantel racemic monohydrate.
Salazar-Rojas D; Maggio RM; Kaufman TS
Eur J Pharm Sci; 2020 Apr; 146():105267. PubMed ID: 32061654
[TBL] [Abstract][Full Text] [Related]
14. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.
Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L
Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701
[TBL] [Abstract][Full Text] [Related]
15. A New Challenge for the Old Excipient Calcium Carbonate: To Improve the Dissolution Rate of Poorly Soluble Drugs.
Ambrogi V
Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678929
[TBL] [Abstract][Full Text] [Related]
16. Structural Elucidation of Poloxamer 237 and Poloxamer 237/Praziquantel Solid Dispersions: Impact of Poly(Vinylpyrrolidone) over Drug Recrystallization and Dissolution.
Orlandi S; Priotti J; Diogo HP; Leonardi D; Salomon CJ; Nunes TG
AAPS PharmSciTech; 2018 Apr; 19(3):1274-1286. PubMed ID: 29313262
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
18. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
[TBL] [Abstract][Full Text] [Related]
19. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and in vitro/vivo evaluation of tectorigenin solid dispersion with improved dissolution and bioavailability.
Shuai S; Yue S; Huang Q; Wang W; Yang J; Lan K; Ye L
Eur J Drug Metab Pharmacokinet; 2016 Aug; 41(4):413-22. PubMed ID: 25669445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
